Exlusive interview with Petrovax Pharm Company, responsible for launching a phase III trial for the COVID-19 vaccine developed by CanSino Biologics Inc. This issue features Nikolay Dodonov, the Head of Medical Department at Petrovax Pharm, sharing first-hand insights on the clinical development process for a COVID-19 vaccine trial.
